This oncolytic adenovirus based Survivin RNA interference could efficiently reduce the cell growth, tumorigenicity and increase apoptosis of colorectal cancer cells, which offers a prospect of improvement in treatment of CRC, even a promising treatment for other human cancers. The gene discussed is BIRC5; the disease is colorectal carcinoma.